An open-label dose-escalation study of once-daily and twice-daily pasireotide in healthy volunteers: safety, tolerability, and effects on glucose, insulin, and glucagon levels. (Q51355360)
Jump to navigation
Jump to search
scientific article published in May 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | An open-label dose-escalation study of once-daily and twice-daily pasireotide in healthy volunteers: safety, tolerability, and effects on glucose, insulin, and glucagon levels. |
scientific article published in May 2014 |
Statements
1 reference
An open-label dose-escalation study of once-daily and twice-daily pasireotide in healthy volunteers: safety, tolerability, and effects on glucose, insulin, and glucagon levels. (English)
1 reference
Magdy Shenouda
1 reference
Mario Maldonado
1 reference
Yanfeng Wang
1 reference
Emmanuel Bouillaud
1 reference
Michelle Hudson
1 reference
Dalal Nesheiwat
1 reference
Ke Hu
1 reference
1 May 2014
1 reference
21
1 reference
3
1 reference
164-173
1 reference
Identifiers
1 reference